Hydroxychloroquine Market Size, Industry Growth Prospects & Trends Analysis

 

Hydroxychloroquine Market



  Hydroxychloroquine is a medication that is commonly used to prevent and treat malaria. The pharmacokinetics of hydroxychloroquine are comparable to chloroquine. It is quickly absorbed in the gastrointestinal tract and excreted by the kidneys. In addition, hydroxychloroquine is used to treat rheumatoid arthritis, lupus erythematosus, and delayed skin lesions purpura.

  India is a significant producer of hydroxychloroquine. The potential of this drug in treating COVID-19 compelled India to impose a ban on its export, resulting in tensions in US–India diplomatic relations. At the moment, approximately 80 countries around the world rely on Indian medicine. Hydroxychloroquine (Plaquenil) is a disease-modifying anti-rheumatic medication. Individuals' high prevalence of joint pain and long-term disability has fueled demand for hydroxychloroquine drugs. Plaquenil has received a lot of attention for its ability to effectively reduce arthritis pain and swelling.

  The hydroxychloroquine market drugs are being driven by an alarmingly high number of childhood arthritis cases and other autoimmune diseases. However, the drug has the potential to cause severe hypoglycemia. Diabetic patients are thus advised to monitor their blood sugar levels on a regular basis. However, in areas where chloroquine resistance has been reported, the hydroxychloroquine market has been found to be ineffective against malaria. As a result, pharmaceutical companies are advocating for a better understanding of the impact of low-quality drugs on malaria control.

  Hydroxychloroquine drugs are the gold standard for malaria treatment. However, in many cases, healthcare professionals have encountered drug resistance in patients, which is likely to have an impact on the market for hydroxychloroquine drugs. As a result, hydroxychloroquine drug manufacturers are taking cues from the WorldWide Antimalarial Resistance Network (WWARN), which facilitates study groups that generate a pooled analysis of the efficacy and safety of hydroxychloroquine drugs.

  Cadila Healthcare Ltd., Hikma Pharmaceuticals PLC, Ipca Laboratories Ltd., Mylan N.V., Novartis AG, Pfizer Inc., Sanofi S.A., Taj Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., and Zydus Cadila are the major players in the hydroxychloroquine industry. The players are constantly focusing on R&D to determine the impact of various coatings on coronavirus.

Paperblog

Comments

Popular posts from this blog

Digital Radiography Market Analysis and Value Chain Study Forecast to 2028 | Siemens, Allengers Medical Systems, Fujifilm Hilding

Home Healthcare Software Market expectation surges with changing trends and higher demand by industry analysis

Shingles Vaccine Market 2021 Growing Demands, Rising Latest Advancements and Business Opportunities